Sirlibz
Yankup,the IT branch of Samsung Group has announced the blockchain pilot dubbed Disruptive Innovation Technology. These technological developments are to help in guaranteeing transparency in the pharmaceutical industry. They plan on launching different pilot programs in November in order to test blockchain-powered machine distribution chains.
The announcement was made at the Biopharma cold chain logistics session in Seoul, South Korea.
“Through the drug distribution history management service, it is possible to comply with regulations and innovate business by implementing product-specific history management, real-time distribution history tracking, and automatic reporting functions.”
The pilots are said to last between three and six months and that they would include an IOT-linked temperature history tracking service. This will be implemented alongside the automatic history management for both incoming and outgoing goods.
“The value of blockchain in the healthcare industry is expected to grow from $176.80 million in 2018 to $5.61 billion in 2025, and by 2025, 55% of healthcare solutions are expected to adopt blockchain for commercial purposes.”
